RecruitingNot ApplicableNCT06931275

Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

Implementing Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes


Sponsor

T1D Exchange, United States

Enrollment

1,178 participants

Start Date

Aug 13, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions. The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA). The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies. Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.


Eligibility

Min Age: 2 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether electronic health record alerts (called "best practice advisories") can encourage doctors to prescribe advanced diabetes technology — like continuous glucose monitors and automated insulin delivery systems — to Black and Hispanic patients with Type 1 diabetes who are less likely to receive these devices despite benefiting from them. **You may be eligible if...** - You are 2 years of age or older - You have a diagnosis of Type 1 diabetes for at least 6 months - You identify as non-Hispanic Black or Hispanic - You receive care at one of the participating diabetes centers **You may NOT be eligible if...** - You are already using an automated insulin delivery (AID) system at the start of the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREMR-based BPA model

Advanced Diabetes Technologies including AIDs, insulin pumps and CGMs will be prescribed to patients after an EMR-based BPA implementation at six centers.

BEHAVIORALPlacebo (EMR-based without BPA model)

Advanced Diabetes Technologies including AIDs, insulin pumps and CGMs will be prescribed to patients after an EMR-based system without BPA at the implementation at six centers.


Locations(2)

T1D Exchange

Boston, Massachusetts, United States

T1D Exchange

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06931275


Related Trials